Evidence map›Paper›PMID 25630570›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Bridging Integrator 1 (BIN1) Genotype Effects on Working Memory, Hippocampal Volume, and Functional Connectivity in Young Healthy Individuals.

Xiaolong Zhang, Jin-Tai Yu, Jin Li, Chao Wang, Lan Tan, Bing Liu, Tianzi Jiang

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Exploring the association betweenFrontiers in neurology · 2025
    Article
  4. Article
  5. Article
  6. Cell type-specific functions of Alzheimer's disease endocytic risk genes.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. National science review · 2019
    Article
  20. [Progress in the study of the imaging genomics of Alzheimer's disease].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaolong Zhang1] Brainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China [2] National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.ORCID 0000000302627854
Jin-Tai Yu1] Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China [2] Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
Jin Li1] Brainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China [2] National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
Chao WangKey Laboratory for NeuroInformation of Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
Lan TanDepartment of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China.
Bing Liu1] Brainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China [2] National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
Tianzi Jiang1] Brainnetome Center, Institute of Automation, Chinese Academy of Sciences, Beijing, China [2] National Laboratory of Pattern Recognition, Institute of Automation, Chinese Academy of Sciences, Beijing, China [3] Key Laboratory for NeuroInformation of Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China [4] Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common form of dementia and exhibits a considerable level of heritability. The bridging integrator 1 (BIN1) gene has recently been identified in several large genome-wide association studies (GWAS) as the second most important risk locus for AD following apolipoprotein E (APOE). However, how and when the established genetic risk locus BIN1 rs744373 confers risk to late-onset AD has yet to be determined. Here using an imaging genetic strategy in large-sample Chinese subjects, we show that healthy homozygous carriers of the rs744373 risk allele exhibit worse high-load working memory (WM) performance, larger hippocampal volume and lower functional connectivity between the bilateral hippocampus and the right dorsolateral prefrontal cortex (DLPFC), mirroring clinical evidence of disturbed memory and connectivity in patients. Our findings demonstrate that rs744373 itself or a variation in linkage disequilibrium may provide a neurogenetic mechanism for BIN1 while further validating the possibility of combining genetic and neuroimaging strategies to monitor individuals at risk for AD.

Indexed as

Adaptor Proteins, Signal TransducingAnalysis of VarianceBrain MappingChi-Square DistributionFemaleGenotypeHealthy VolunteersHippocampusHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleMemory, Short-TermNeuropsychological TestsNuclear ProteinsOxygenAdaptor Proteins, Signal TransducingBIN1 protein, humanNuclear ProteinsOxygenTumor Suppressor Proteins

Identifiers

PMID25630570
PMCPMC4915264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.